These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22017582)

  • 1. Pathogenesis of NUT midline carcinoma.
    French CA
    Annu Rev Pathol; 2012; 7():247-65. PubMed ID: 22017582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of diagnosing NUT midline carcinoma.
    French CA
    Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.
    Grayson AR; Walsh EM; Cameron MJ; Godec J; Ashworth T; Ambrose JM; Aserlind AB; Wang H; Evan G; Kluk MJ; Bradner JE; Aster JC; French CA
    Oncogene; 2014 Mar; 33(13):1736-1742. PubMed ID: 23604113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.
    French CA; Ramirez CL; Kolmakova J; Hickman TT; Cameron MJ; Thyne ME; Kutok JL; Toretsky JA; Tadavarthy AK; Kees UR; Fletcher JA; Aster JC
    Oncogene; 2008 Apr; 27(15):2237-42. PubMed ID: 17934517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.
    French CA; Rahman S; Walsh EM; Kühnle S; Grayson AR; Lemieux ME; Grunfeld N; Rubin BP; Antonescu CR; Zhang S; Venkatramani R; Dal Cin P; Howley PM
    Cancer Discov; 2014 Aug; 4(8):928-41. PubMed ID: 24875858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demystified molecular pathology of NUT midline carcinomas.
    French CA
    J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
    Fang W; French CA; Cameron MJ; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
    Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
    Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
    Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NUT midline carcinoma.
    French CA
    Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
    Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
    Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
    French CA
    Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of NUT midline carcinoma by epigenomic reprogramming.
    Schwartz BE; Hofer MD; Lemieux ME; Bauer DE; Cameron MJ; West NH; Agoston ES; Reynoird N; Khochbin S; Ince TA; Christie A; Janeway KA; Vargas SO; Perez-Atayde AR; Aster JC; Sallan SE; Kung AL; Bradner JE; French CA
    Cancer Res; 2011 Apr; 71(7):2686-96. PubMed ID: 21447744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
    Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
    Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic findings of NUT midline carcinoma in the hilum of the lung.
    Policarpio-Nicolas ML; de Leon EM; Jagirdar J
    Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
    Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
    Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns.
    Zee BM; Dibona AB; Alekseyenko AA; French CA; Kuroda MI
    PLoS One; 2016; 11(10):e0163820. PubMed ID: 27698495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.
    Wang R; Liu W; Helfer CM; Bradner JE; Hornick JL; Janicki SM; French CA; You J
    Cancer Res; 2014 Jun; 74(12):3332-43. PubMed ID: 24736545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUT midline carcinoma of the larynx: an international series and review of the literature.
    Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
    Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.